| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $958K | — | +32.9% |
| Cost of Revenue | $723K | — | +53.8% |
| Gross Profit | $235K | — | -6.4% |
| R&D Expense | $689K | — | +1.2% |
| SG&A Expense | $734K | — | +2.5% |
| Operating Income | -$1.9M | — | -2.8% |
| Net Income | -$2.5M | — | -32.0% |
| EPS (Basic) | -$0.16 | — | +27.3% |
| EPS (Diluted) | -$0.16 | — | +27.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $7.5M | +86.0% | +572.5% |
| Accounts Receivable | $930K | -12.1% | -24.6% |
| Inventory | $2.3M | -6.9% | -8.6% |
| Current Assets | $11.4M | +33.3% | +95.8% |
| Total Assets | $12.8M | +34.6% | +80.6% |
| Current Liabilities | $2.6M | -25.2% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$1.9M | — | +12.5% |
| Capital Expenditures | $45K | — | — |
| Investing Cash Flow | -$41K | — | -4200.0% |
| Financing Cash Flow | $5.1M | — | +285.2% |
| Free Cash Flow | -$1.9M | — | — |
| -30.1% |
| Long-term Debt | $150K | +0.0% | +0.0% |
| Total Liabilities | $4.5M | -4.6% | +5.0% |
| Stockholders' Equity | $8.3M | +73.3% | +222.5% |